
|Articles|November 1, 2006
Breast cancer risk in subset of OC users
Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
DARE to PLAY sildenafil cream becomes commercially available for women in select states
2
George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia
3
FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea
4
Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea
5










